Nucleic-acid testing, new platforms and nanotechnology for point-of-decision diagnosis of animal pathogens.
Accurate disease diagnosis in animals is crucial for animal well-being but also for preventing zoonosis transmission to humans. In particular, livestock diseases may constitute severe threats to humans due to the particularly high physical contact and exposure and, also, be the cause of important economic losses, even in non-endemic countries, where they often arise in the form of rapid and devastating epidemics. Rapid diagnostic tests have been used for a long time in field situations, particularly during outbreaks. However, they mostly rely on serological approaches, which may confirm the exposure to a particular pathogen but may be inappropriate for point-of-decision (point-of-care) settings when emergency responses supported on early and accurate diagnosis are required. Moreover, they often exhibit modest sensitivity and hence significantly depend on later result confirmation in central or reference laboratories. The impressive advances observed in recent years in materials sciences and in nanotechnology, as well as in nucleic-acid synthesis and engineering, have led to an outburst of new in-the-bench and prototype tests for nucleic-acid testing towards point-of-care diagnosis of genetic and infectious diseases. Manufacturing, commercial, regulatory, and technical nature issues for field applicability more likely have hindered their wider entrance into veterinary medicine and practice than have fundamental science gaps. This chapter begins by outlining the current situation, requirements, difficulties, and perspectives of point-of-care tests for diagnosing diseases of veterinary interest. Nucleic-acid testing, particularly for the point of care, is addressed subsequently. A range of valuable signal transduction mechanisms commonly employed in proof-of-concept schemes and techniques born on the analytical chemistry laboratories are also described. As the essential core of this chapter, sections dedicated to the principles and applications of microfluidics, lab-on-a-chip, and nanotechnology for the development of point-of-care tests are presented. Microdevices already applied or under development for application in field diagnosis of animal diseases are reviewed.
Laboratory of Mycology/Microbiology Unit and Centre for Malaria and Tropical Diseases (CMDT), Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (UNL), Lisboa, Portugal, ferteles@hotmail.com.
Fernando
F
Teles
Luís
L
Fonseca
D000820:Animal Diseases / Q000175:diagnosis* / Q000209:etiology*; D000818:Animals; D003141:Communicable Diseases / Q000662:veterinary*; D056656:Lab-On-A-Chip Devices; D044085:Microfluidics / Q000379:methods; D025202:Molecular Diagnostic Techniques; D036103:Nanotechnology / Q000379:methods*; D021141:Nucleic Acid Amplification Techniques; D019095:Point-of-Care Systems